BetterScholar BetterScholar
10
Role
Title
Level Year L/R
🐜 Towards the sustainable discovery and development of new antibiotics
54 auth. M. Miethke, Marco Pieroni, T. Weber, M. Brönstrup, P. Hammann, L. Halby, P. Arimondo, P. Glaser, B. Aigle, H. Bode, R. Moreira, Yanyan Li, A. Luzhetskyy, M. Medema, J. Pernodet, ... M. Stadler, J. Tormo, O. Genilloud, A. Truman, K. Weissman, E. Takano, S. Sabatini, E. Stegmann, H. Brötz-Oesterhelt, W. Wohlleben, M. Seemann, M. Empting, A. Hirsch, B. Loretz, C. Lehr, A. Titz, J. Herrmann, T. Jaeger, S. Alt, T. Hesterkamp, M. Winterhalter, Andrea Schiefer, K. Pfarr, A. Hoerauf, H. Graz, M. Graz, M. Lindvall, S. Ramurthy, A. Karlén, Maarten B M van Dongen, H. Petković, A. Keller, F. Peyrane, S. Donadio, L. Fraisse, L. Piddock, I. Gilbert, H. Moser, Rolf Müller
9 2021
9
🐜
🐢 Novel Strategies for the Treatment of Pseudomonas aeruginosa Infections.
7 auth. S. Wagner, R. Sommer, Stefan Hinsberger, Cenbin Lu, R. Hartmann, M. Empting, ... A. Titz
7 2016
7
🐢
🐬 Innate Immunity Mediates Follicular Transport of Particulate but Not Soluble Protein Antigen
A. Link, Franziska Zabel, Yvonne Schnetzler, A. Titz, F. Brombacher, M. Bachmann
7 2012
7
🐬
🐢 Glycomimetic, Orally Bioavailable LecB Inhibitors Block Biofilm Formation of Pseudomonas aeruginosa.
14 auth. R. Sommer, S. Wagner, K. Rox, A. Varrot, D. Hauck, Eike-Christian Wamhoff, Janine Schreiber, T. Ryckmans, T. Brunner, C. Rademacher, ... R. Hartmann, M. Brönstrup, A. Imberty, A. Titz
6 2017
6
🐢
🐜 Caenorhabditis elegans N-glycan Core β-galactoside Confers Sensitivity towards Nematotoxic Fungal Galectin CGL2
12 auth. Alex Butschi, A. Titz, M. Wälti, Vincent Olieric, K. Paschinger, Katharina Nöbauer, ... Xiaoqiang Guo, P. Seeberger, I. Wilson, M. Aebi, M. Hengartner, M. Künzler
6 2010
6
🐜
🐜 Methylated glycans as conserved targets of animal and fungal innate defense
14 auth. Therese Wohlschlager, Alex Butschi, P. Grassi, Grigorij Sutov, R. Gauss, D. Hauck, Stefanie S. Schmieder, Martin Knobel, A. Titz, A. Dell, ... S. Haslam, M. Hengartner, M. Aebi, M. Künzler
6 2014
6
🐜
🐢 Discovery of two classes of potent glycomimetic inhibitors of Pseudomonas aeruginosa LecB with distinct binding modes.
9 auth. D. Hauck, I. Joachim, B. Frommeyer, A. Varrot, B. Philipp, H. Möller, ... A. Imberty, T. Exner, A. Titz
6 2013
6
🐢
🦁 A safe and convenient method for the preparation of triflyl azide, and its use in diazo transfer reactions to primary amines
A. Titz, Z. Radić, O. Schwardt, B. Ernst
6 2006
6
🦁
🐢 Pathoblockers or antivirulence drugs as a new option for the treatment of bacterial infections
M. Calvert, V. R. Jumde, A. Titz
6 2018
6
🐢
🐜 Ciprofloxacin-loaded lipid-core nanocapsules as mucus penetrating drug delivery system intended for the treatment of bacterial infections in cystic fibrosis.
9 auth. A. Torge, S. Wagner, P. Chaves, E. G. Oliveira, S. Guterres, A. Pohlmann, ... A. Titz, Marc Schneider, R. Beck
6 2017
6
🐜